Report Detail

Pharma & Healthcare Global Transdermal Drug Patches Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

  • RnM3144893
  • |
  • 11 January, 2024
  • |
  • Global
  • |
  • 133 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Transdermal Drug Patches market size was valued at USD 7028.9 million in 2023 and is forecast to a readjusted size of USD 7952.9 million by 2030 with a CAGR of 1.8% during review period.
Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.
Global key players of transdermal drug patches include Hisamitsu Pharmaceutical, Johnson & Johnson, Mylan, UCB Pharma, Novartis, etc. The top five players hold a share about 37%. North America is the largest market, has a share about 50%, followed by Europe and Asia-Pacific, both have a share about 24 percent.
The Global Info Research report includes an overview of the development of the Transdermal Drug Patches industry chain, the market status of Rx Channel (Methyl Salicylate-based Patch, Rivastigmine Transdermal Patch), OTC Channel (Methyl Salicylate-based Patch, Rivastigmine Transdermal Patch), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Transdermal Drug Patches.
Regionally, the report analyzes the Transdermal Drug Patches markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Transdermal Drug Patches market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Transdermal Drug Patches market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Transdermal Drug Patches industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (M Pieces), revenue generated, and market share of different by Type (e.g., Methyl Salicylate-based Patch, Rivastigmine Transdermal Patch).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Transdermal Drug Patches market.
Regional Analysis: The report involves examining the Transdermal Drug Patches market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Transdermal Drug Patches market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Transdermal Drug Patches:
Company Analysis: Report covers individual Transdermal Drug Patches manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Transdermal Drug Patches This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Rx Channel, OTC Channel).
Technology Analysis: Report covers specific technologies relevant to Transdermal Drug Patches. It assesses the current state, advancements, and potential future developments in Transdermal Drug Patches areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Transdermal Drug Patches market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Transdermal Drug Patches market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Methyl Salicylate-based Patch
Rivastigmine Transdermal Patch
Fentanyl Transdermal Patch
Lidocaine Patch
Diclofenac Patch
Nicotine Transdermal Patch
Others
Market segment by Application
Rx Channel
OTC Channel
Major players covered
Hisamitsu Pharmaceutical
Johnson & Johnson
Mylan
UCB Pharma
Novartis
Teva Pharmaceutical
Beijing Tide Pharmaceutical
Chattem
Nitto Denko
Grünenthal
Mundipharma
GSK
Luye Pharma Group
Bayer
IBSA Group
Dr Reddy’s Laboratories
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Transdermal Drug Patches product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Transdermal Drug Patches, with price, sales, revenue and global market share of Transdermal Drug Patches from 2019 to 2024.
Chapter 3, the Transdermal Drug Patches competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Transdermal Drug Patches breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Transdermal Drug Patches market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Transdermal Drug Patches.
Chapter 14 and 15, to describe Transdermal Drug Patches sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Transdermal Drug Patches
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Transdermal Drug Patches Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Methyl Salicylate-based Patch
    • 1.3.3 Rivastigmine Transdermal Patch
    • 1.3.4 Fentanyl Transdermal Patch
    • 1.3.5 Lidocaine Patch
    • 1.3.6 Diclofenac Patch
    • 1.3.7 Nicotine Transdermal Patch
    • 1.3.8 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Transdermal Drug Patches Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Rx Channel
    • 1.4.3 OTC Channel
  • 1.5 Global Transdermal Drug Patches Market Size & Forecast
    • 1.5.1 Global Transdermal Drug Patches Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Transdermal Drug Patches Sales Quantity (2019-2030)
    • 1.5.3 Global Transdermal Drug Patches Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Hisamitsu Pharmaceutical
    • 2.1.1 Hisamitsu Pharmaceutical Details
    • 2.1.2 Hisamitsu Pharmaceutical Major Business
    • 2.1.3 Hisamitsu Pharmaceutical Transdermal Drug Patches Product and Services
    • 2.1.4 Hisamitsu Pharmaceutical Transdermal Drug Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Hisamitsu Pharmaceutical Recent Developments/Updates
  • 2.2 Johnson & Johnson
    • 2.2.1 Johnson & Johnson Details
    • 2.2.2 Johnson & Johnson Major Business
    • 2.2.3 Johnson & Johnson Transdermal Drug Patches Product and Services
    • 2.2.4 Johnson & Johnson Transdermal Drug Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Johnson & Johnson Recent Developments/Updates
  • 2.3 Mylan
    • 2.3.1 Mylan Details
    • 2.3.2 Mylan Major Business
    • 2.3.3 Mylan Transdermal Drug Patches Product and Services
    • 2.3.4 Mylan Transdermal Drug Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Mylan Recent Developments/Updates
  • 2.4 UCB Pharma
    • 2.4.1 UCB Pharma Details
    • 2.4.2 UCB Pharma Major Business
    • 2.4.3 UCB Pharma Transdermal Drug Patches Product and Services
    • 2.4.4 UCB Pharma Transdermal Drug Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 UCB Pharma Recent Developments/Updates
  • 2.5 Novartis
    • 2.5.1 Novartis Details
    • 2.5.2 Novartis Major Business
    • 2.5.3 Novartis Transdermal Drug Patches Product and Services
    • 2.5.4 Novartis Transdermal Drug Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Novartis Recent Developments/Updates
  • 2.6 Teva Pharmaceutical
    • 2.6.1 Teva Pharmaceutical Details
    • 2.6.2 Teva Pharmaceutical Major Business
    • 2.6.3 Teva Pharmaceutical Transdermal Drug Patches Product and Services
    • 2.6.4 Teva Pharmaceutical Transdermal Drug Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Teva Pharmaceutical Recent Developments/Updates
  • 2.7 Beijing Tide Pharmaceutical
    • 2.7.1 Beijing Tide Pharmaceutical Details
    • 2.7.2 Beijing Tide Pharmaceutical Major Business
    • 2.7.3 Beijing Tide Pharmaceutical Transdermal Drug Patches Product and Services
    • 2.7.4 Beijing Tide Pharmaceutical Transdermal Drug Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Beijing Tide Pharmaceutical Recent Developments/Updates
  • 2.8 Chattem
    • 2.8.1 Chattem Details
    • 2.8.2 Chattem Major Business
    • 2.8.3 Chattem Transdermal Drug Patches Product and Services
    • 2.8.4 Chattem Transdermal Drug Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Chattem Recent Developments/Updates
  • 2.9 Nitto Denko
    • 2.9.1 Nitto Denko Details
    • 2.9.2 Nitto Denko Major Business
    • 2.9.3 Nitto Denko Transdermal Drug Patches Product and Services
    • 2.9.4 Nitto Denko Transdermal Drug Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Nitto Denko Recent Developments/Updates
  • 2.10 Grünenthal
    • 2.10.1 Grünenthal Details
    • 2.10.2 Grünenthal Major Business
    • 2.10.3 Grünenthal Transdermal Drug Patches Product and Services
    • 2.10.4 Grünenthal Transdermal Drug Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Grünenthal Recent Developments/Updates
  • 2.11 Mundipharma
    • 2.11.1 Mundipharma Details
    • 2.11.2 Mundipharma Major Business
    • 2.11.3 Mundipharma Transdermal Drug Patches Product and Services
    • 2.11.4 Mundipharma Transdermal Drug Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Mundipharma Recent Developments/Updates
  • 2.12 GSK
    • 2.12.1 GSK Details
    • 2.12.2 GSK Major Business
    • 2.12.3 GSK Transdermal Drug Patches Product and Services
    • 2.12.4 GSK Transdermal Drug Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 GSK Recent Developments/Updates
  • 2.13 Luye Pharma Group
    • 2.13.1 Luye Pharma Group Details
    • 2.13.2 Luye Pharma Group Major Business
    • 2.13.3 Luye Pharma Group Transdermal Drug Patches Product and Services
    • 2.13.4 Luye Pharma Group Transdermal Drug Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 Luye Pharma Group Recent Developments/Updates
  • 2.14 Bayer
    • 2.14.1 Bayer Details
    • 2.14.2 Bayer Major Business
    • 2.14.3 Bayer Transdermal Drug Patches Product and Services
    • 2.14.4 Bayer Transdermal Drug Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.14.5 Bayer Recent Developments/Updates
  • 2.15 IBSA Group
    • 2.15.1 IBSA Group Details
    • 2.15.2 IBSA Group Major Business
    • 2.15.3 IBSA Group Transdermal Drug Patches Product and Services
    • 2.15.4 IBSA Group Transdermal Drug Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.15.5 IBSA Group Recent Developments/Updates
  • 2.16 Dr Reddy’s Laboratories
    • 2.16.1 Dr Reddy’s Laboratories Details
    • 2.16.2 Dr Reddy’s Laboratories Major Business
    • 2.16.3 Dr Reddy’s Laboratories Transdermal Drug Patches Product and Services
    • 2.16.4 Dr Reddy’s Laboratories Transdermal Drug Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.16.5 Dr Reddy’s Laboratories Recent Developments/Updates

3 Competitive Environment: Transdermal Drug Patches by Manufacturer

  • 3.1 Global Transdermal Drug Patches Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Transdermal Drug Patches Revenue by Manufacturer (2019-2024)
  • 3.3 Global Transdermal Drug Patches Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Transdermal Drug Patches by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Transdermal Drug Patches Manufacturer Market Share in 2023
    • 3.4.2 Top 6 Transdermal Drug Patches Manufacturer Market Share in 2023
  • 3.5 Transdermal Drug Patches Market: Overall Company Footprint Analysis
    • 3.5.1 Transdermal Drug Patches Market: Region Footprint
    • 3.5.2 Transdermal Drug Patches Market: Company Product Type Footprint
    • 3.5.3 Transdermal Drug Patches Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Transdermal Drug Patches Market Size by Region
    • 4.1.1 Global Transdermal Drug Patches Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Transdermal Drug Patches Consumption Value by Region (2019-2030)
    • 4.1.3 Global Transdermal Drug Patches Average Price by Region (2019-2030)
  • 4.2 North America Transdermal Drug Patches Consumption Value (2019-2030)
  • 4.3 Europe Transdermal Drug Patches Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Transdermal Drug Patches Consumption Value (2019-2030)
  • 4.5 South America Transdermal Drug Patches Consumption Value (2019-2030)
  • 4.6 Middle East and Africa Transdermal Drug Patches Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Transdermal Drug Patches Sales Quantity by Type (2019-2030)
  • 5.2 Global Transdermal Drug Patches Consumption Value by Type (2019-2030)
  • 5.3 Global Transdermal Drug Patches Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Transdermal Drug Patches Sales Quantity by Application (2019-2030)
  • 6.2 Global Transdermal Drug Patches Consumption Value by Application (2019-2030)
  • 6.3 Global Transdermal Drug Patches Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Transdermal Drug Patches Sales Quantity by Type (2019-2030)
  • 7.2 North America Transdermal Drug Patches Sales Quantity by Application (2019-2030)
  • 7.3 North America Transdermal Drug Patches Market Size by Country
    • 7.3.1 North America Transdermal Drug Patches Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Transdermal Drug Patches Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Transdermal Drug Patches Sales Quantity by Type (2019-2030)
  • 8.2 Europe Transdermal Drug Patches Sales Quantity by Application (2019-2030)
  • 8.3 Europe Transdermal Drug Patches Market Size by Country
    • 8.3.1 Europe Transdermal Drug Patches Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Transdermal Drug Patches Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Transdermal Drug Patches Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Transdermal Drug Patches Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Transdermal Drug Patches Market Size by Region
    • 9.3.1 Asia-Pacific Transdermal Drug Patches Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Transdermal Drug Patches Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Transdermal Drug Patches Sales Quantity by Type (2019-2030)
  • 10.2 South America Transdermal Drug Patches Sales Quantity by Application (2019-2030)
  • 10.3 South America Transdermal Drug Patches Market Size by Country
    • 10.3.1 South America Transdermal Drug Patches Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Transdermal Drug Patches Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Transdermal Drug Patches Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Transdermal Drug Patches Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Transdermal Drug Patches Market Size by Country
    • 11.3.1 Middle East & Africa Transdermal Drug Patches Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Transdermal Drug Patches Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Transdermal Drug Patches Market Drivers
  • 12.2 Transdermal Drug Patches Market Restraints
  • 12.3 Transdermal Drug Patches Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Transdermal Drug Patches and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Transdermal Drug Patches
  • 13.3 Transdermal Drug Patches Production Process
  • 13.4 Transdermal Drug Patches Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Transdermal Drug Patches Typical Distributors
  • 14.3 Transdermal Drug Patches Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Transdermal Drug Patches . Industry analysis & Market Report on Transdermal Drug Patches is a syndicated market report, published as Global Transdermal Drug Patches Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Transdermal Drug Patches market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,787.48
    4,181.22
    5,574.96
    3,250.32
    4,875.48
    6,500.64
    548,065.20
    822,097.80
    1,096,130.40
    290,197.20
    435,295.80
    580,394.40
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report